Bupi Yishen formula attenuates kidney injury in 5/6 nephrectomized rats via the tryptophan-kynurenic acid-aryl hydrocarbon receptor pathway

BACKGROUND: Bupi Yishen Formula (BYF), a patent traditional Chinese medicine (TCM) formulation, has been used in the clinical treatment of chronic kidney disease (CKD). However, the mechanism of action of BYF has not been fully elucidated. METHOD: To investigate the variation in the metabolic profil...

Descripción completa

Detalles Bibliográficos
Autores principales: Mo, Yenan, Jie, Xina, Wang, Lixin, Ji, Chunlan, Gu, Yueyu, Lu, Zhaoyu, Liu, Xusheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8353787/
https://www.ncbi.nlm.nih.gov/pubmed/34376166
http://dx.doi.org/10.1186/s12906-021-03376-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8353787/
https://www.ncbi.nlm.nih.gov/pubmed/34376166
http://dx.doi.org/10.1186/s12906-021-03376-1

Ejemplares similares